These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15206098)

  • 21. Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.
    Runge VM; Carollo BR; Wolf CR; Nelson KL; Gelblum DY
    Radiographics; 1989 Sep; 9(5):929-58. PubMed ID: 2678298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M; Schwarcz A; Randhawa MS; Marton B; Kardos L; Palkó A
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primovist, Eovist: what to expect?
    Van Beers BE; Pastor CM; Hussain HK
    J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging of periosteum with ultrashort TE pulse sequences.
    Reichert IL; Benjamin M; Gatehouse PD; Chappell KE; Holmes J; He T; Bydder GM
    J Magn Reson Imaging; 2004 Jan; 19(1):99-107. PubMed ID: 14696226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary and emerging technologies in abdominal magnetic resonance imaging.
    Liu PS; Hussain HK
    Semin Roentgenol; 2013 Jul; 48(3):203-13. PubMed ID: 23796371
    [No Abstract]   [Full Text] [Related]  

  • 26. MRI agents for abdomen offer high sensitivity.
    D'Agincourt L
    Diagn Imaging (San Franc); 1992 Aug; 14(8):78-85. PubMed ID: 10147536
    [No Abstract]   [Full Text] [Related]  

  • 27. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of gadolinium-DTPA in the study of the urinary bladder].
    Beyer HK; Blümm R; Hötzinger H
    Rontgenpraxis; 1988 Feb; 41(2):57-64. PubMed ID: 3363435
    [No Abstract]   [Full Text] [Related]  

  • 29. Breast magnetic resonance imaging: principles and techniques.
    Kaiser WA
    Semin Roentgenol; 2007 Oct; 42(4):228-35. PubMed ID: 17919525
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative evaluation of the SPIR sequence with gadolinium and other sequences in bone diseases].
    Cova M; Frezza F; Chalkias S; Ukmar M; Pozzi Mucelli R
    Radiol Med; 1993 Apr; 85(4):370-7. PubMed ID: 8516461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future applications of contrast agents for magnetic resonance imaging of the central nervous system.
    Bradley WG
    Invest Radiol; 1992 Aug; 27 Suppl 1():S58-60. PubMed ID: 1506155
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed contrast enhancement magnetic resonance imaging for the assessment of cardiac disease.
    Marcu CB; Nijveldt R; Beek AM; Van Rossum AC
    Heart Lung Circ; 2007 Apr; 16(2):70-8. PubMed ID: 17317312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contrast media for nuclear magnetic resonance tomography].
    Schwing C
    Digitale Bilddiagn; 1990 Mar; 10(1):36-8. PubMed ID: 2354594
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of brain metastases by magnetic resonance imaging: which magnetic resonance imaging sequence works best?
    Tikkakoski T
    Acta Radiol; 2008 Dec; 49(10):1097-8. PubMed ID: 18941952
    [No Abstract]   [Full Text] [Related]  

  • 35. [Initial experience with the use of oral gadolinium-DTPA in nuclear magnetic resonance tomography of the pelvis].
    Hötzinger H; Salbeck R; Toedt C; Beyer HK
    Digitale Bilddiagn; 1990 Jun; 10(2):42-5. PubMed ID: 2208914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model.
    Flacke S; Allen JS; Chia JM; Wible JH; Periasamy MP; Adams MD; Adzamli IK; Lorenz CH
    Radiology; 2003 Mar; 226(3):731-8. PubMed ID: 12601183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Magnetic-resonance urography: experience os using small doses of Gd-DTPA and amplification of contrast techniques].
    Sviridov NK; Napolov IuK
    Urologiia; 2002; (1):53. PubMed ID: 11877978
    [No Abstract]   [Full Text] [Related]  

  • 39. Gd-EOB-DTPA-enhanced magnetic resonance imaging findings of nondiffuse fatty change of the liver.
    Yamamoto A; Tamada T; Sone T; Higashi H; Yamashita T; Ito K
    J Comput Assist Tomogr; 2010; 34(6):868-73. PubMed ID: 21084902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multilocus binding increases the relaxivity of protein-bound MRI contrast agents.
    Zhang Z; Greenfield MT; Spiller M; McMurry TJ; Lauffer RB; Caravan P
    Angew Chem Int Ed Engl; 2005 Oct; 44(41):6766-9. PubMed ID: 16173108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.